Printer friendly

What does MAP stand for?

MAP stands for Mitogen-Activated Protein

This definition appears very rarely and is found in the following Acronym Finder categories:

  • Science, medicine, engineering, etc.

See other meanings of MAP

Other Resources:
We have 1137 other definitions for MAP in our Acronym Attic

Samples in periodicals archive:

Discussion encompasses climate change and food security, genetic engineering for acid soil tolerance in plants, mitogen-activated protein kinases in abiotic stress tolerance in crop plants, and the roles of plant viruses (maybe they're not always villains), as well as the specifics of rice, pearl millet, bamboo, groundnuts, and chickpeas, among other topics.
Watts and his team discovered that enzymes known as mitogen-activated protein kinases form a critical link between changes in blood glucose levels, certain neurons in the hypothalamus, and the release of glucose-control ling hormones.
We show that p38 mitogen-activated protein kinase (p38 MAPK) phosphorylates the spliced form of X-box binding protein 1 (Xbp1s) on its Thr48 and Ser61 residues and greatly enhances its nuclear migration in mice, whereas mutation of either residue to alanine substantially reduces its nuclear translocation and activity.
Among their topics are myth and science regarding laser and light therapy for acne, emerging trends in the diagnosis and management of atopic dermatitis, which side mitogen-activated protein kinases and their inhibitors are on in the fight against psoriasis, dendritic cell immunotherapy for treating malignant melanoma, malignant melanoma in ethnic skin, a novel transdermal drug delivery system mediated by arginine-rich intracellular delivery peptides, and onychomysosis caused by non-dermatophytic filamentous fungi.
HER2 overexpression results in activation of multiple intracellular signalling pathways, including the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) cascades which act to modulate cellular proliferative and survival responses, and tumours overexpressing HER2 have been found to be more aggressive in comparison with tumours that do not.